The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.
New UCD – WMH Volumes Dataset is Now Available
New dataset from UCD on white matter hyperintensities is now available in the Study...
Updated Neuropsych Summary Scores AvailableMore News >
Updated neuropsych summary scores generated by the Crane Lab (UW) are available from the...